Markets:

Overview

News

Currencies

International

Treasuries

Elanco Animal Health Incorporated Common Stock (NY:ELAN)

25.18 -0.00 (-0.02%)

Streaming Delayed Price Updated: 2:03 PM EDT, Mar 18, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Elanco Animal Health Incorporated Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

3 Value Stocks in the Doghouse

April 11, 2025

Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are...

Via StockStory

Peering Into Elanco Animal Health's Recent Short Interest ↗

March 21, 2025

Via Benzinga

Q4 Earnings Roundup: Elanco (NYSE:ELAN) And The Rest Of The Pharmaceuticals Segment

March 18, 2025

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how pharmaceuticals stocks fared in Q4, starting with Elanco...

Via StockStory

Topics Artificial Intelligence Intellectual Property

1 Small-Cap Stock to Target This Week and 2 to Turn Down

March 17, 2025

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a...

Via StockStory

Earnings Scheduled For February 25, 2025 ↗

February 25, 2025

Via Benzinga

Beyond The Numbers: 5 Analysts Discuss Elanco Animal Health Stock ↗

February 21, 2025

Via Benzinga

(ELAN) - Analyzing Elanco Animal Health's Short Interest ↗

February 10, 2025

Via Benzinga

Earnings Scheduled For May 7, 2025 ↗

May 07, 2025

Via Benzinga

Elanco (ELAN) Reports Q1: Everything You Need To Know Ahead Of Earnings

May 06, 2025

Animal health company Elanco (NYSE:ELAN) will be reporting results tomorrow before market hours. Here’s what to look for.

Via StockStory

Topics Artificial Intelligence

Elanco Animal Health Sells Xdemvy Royalties To Blackstone in $295 Million Deal ↗

May 05, 2025

Elanco sells U.S. Xdemvy royalties to Blackstone for $295 million, aiming to lower debt and cut interest costs while retaining global rights.

Via Benzinga

3 Volatile Stocks with Questionable Fundamentals

April 28, 2025

A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some investors embrace risk, mistakes can be costly for those who aren’t prepared.

Via StockStory

3 Profitable Stocks Walking a Fine Line

April 24, 2025

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my...

Via StockStory

What Does the Market Think About Elanco Animal Health? ↗

April 21, 2025

Via Benzinga

Top 3 Health Care Stocks That Could Blast Off In December ↗

December 04, 2024

Via Benzinga

Analyst Ratings For Elanco Animal Health ↗

December 02, 2024

Via Benzinga

3 Reasons to Sell ELAN and 1 Stock to Buy Instead

March 14, 2025

Elanco has gotten torched over the last six months - since September 2024, its stock price has dropped 28.5% to $10.39 per share. This was partly due to its softer quarterly results and might have...

Via StockStory

3 Stocks Under $50 in Hot Water

March 07, 2025

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to...

Via StockStory

Tesla To $370? Here Are 10 Top Analyst Forecasts For Thursday ↗

March 06, 2025

Via Benzinga

Elanco Animal's Outlook Lags Street Expectations But Analyst Sees Time For Elanco's Commercial Investment To Payoff ↗

February 25, 2025

Elanco's Q4 revenue reached $1.02 billion, topping estimates, but EPS missed forecasts. 2025 guidance lags consensus as currency headwinds pose a $110 million challenge.

Via Benzinga

Evaluating Elanco Animal Health: Insights From 4 Financial Analysts ↗

October 28, 2024

Via Benzinga

Demystifying Elanco Animal Health: Insights From 4 Analyst Reviews ↗

September 19, 2024

Via Benzinga

Elanco Animal Health (ELAN) Q4 2024 Earnings Call Transcript ↗

February 25, 2025

ELAN earnings call for the period ending December 31, 2024.

Via The Motley Fool

Topics Earnings

Elanco (NYSE:ELAN) Surprises With Q4 Sales

February 25, 2025

Animal health company Elanco (NYSE:ELAN) reported Q4 CY2024 results exceeding the market’s revenue expectations, but sales fell by 1.4% year on year to $1.02 billion. On the other hand, the company’s...

Via StockStory

Elanco (ELAN) Q4 Earnings Report Preview: What To Look For

February 24, 2025

Animal health company Elanco (NYSE:ELAN) will be announcing earnings results tomorrow before market open. Here’s what to look for.

Via StockStory

Jim Cramer: AMD Is A 'Great' Company, Hold Onto Dow Inc. ↗

January 22, 2025

Cramer says people believe AMD "will not be able to deliver on this quarter" and so he's reluctant to get in.

Via Benzinga

Topics Stocks

Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More ↗

December 22, 2024

JP Morgan highlights 2025 growth prospects for biopharma, animal health, and specialty pharma stocks. Key picks include Eli Lilly, Zoetis, and Bristol-Myers Squibb.

Via Benzinga

This Six Flags Entertainment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗

December 09, 2024

Via Benzinga

Elanco Animal Health (ELAN) Q3 2024 Earnings Call Transcript ↗

November 07, 2024

ELAN earnings call for the period ending September 30, 2024.

Via The Motley Fool

Topics Earnings

Elanco Animal Q3 Earnings: Profit Beat, New Products And Stabilized Business To Drive 2025 Sales ↗

November 07, 2024

Elanco Animal Health reports Q3 revenue of $1.03 billion, with a 4% decline and adjusted EPS of $0.13, beating estimates. Guidance tightened for 2024 sales and EPS.

Via Benzinga

Elanco's Dermatology Treatment Secures FDA Approval For Itchy Dogs, Analyst Highlights Label Warnings And Efficacy ↗

September 20, 2024

FDA approves Elanco's once-daily oral treatment, Zenrelia, for controlling itching in dogs with allergic and atopic dermatitis. The drug, proven effective in studies, faces adoption challenges due to...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.